Companies That Could Issue Positive Earnings Surprises
The fiscal second-quarter consensus earnings estimate for Immucor, Inc. (Nasdaq: BLUD - News) has risen by a penny over the past 30 days to 21 cents per share. The most accurate estimate is even more bullish at 24 cents per share. The reagent manufacturer has topped expectations for 3 consecutive quarters by an average margin of 4 cents per share. Immucor is scheduled to report on Wednesday, Jan 7, after the close of trading.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment